Marinus Pharma falls after missing Q2 revenue estimates

Marinus Pharmaceuticals

13/08/2024 13:08

** Shares of drugmaker Marinus Pharmaceuticals  MRNS.O  
fall 2.9% to $1.20 premarket
    ** Co's Q2 rev. $8.06 mln misses Wall Street estimates of
$9.5 mln - LSEG 
    ** MRNS's Q2 loss of 63 cents/shr is wider than 61 cents/shr
a year ago
    ** Up to last close, stock down 88.7% YTD

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))